PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26124N0566Fluzone trivalent PF HD syringe — Sanofi Pasteur Inc

Sanofi Pasteur Inc holds $3.7B across 396 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 36E79724D0006. PoP ended Oct 31, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

261-Network Contract Office 21 (36C261)
Awarding office
Sanofi Pasteur Inc
Recipient
Oct 31, 2024
PoP end
$269K
Obligated
$269K
Potential
325412
NAICS
6505
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal
Contract number36C26124N0566
Also listed as36C261-24-N-0566
Also listed as36E79724D0006-36C26124N0566
Agency261-Network Contract Office 21 (36C261)
Awarding office261-Network Contract Office 21 (36C261)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentSanofi Pasteur Inc
CAGE7V915
UEINCXBGGQ8YTU9
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36E79724D0006
Place of performanceSWIFTWATER PA
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startApr 10, 2024
PoP end (current)Oct 31, 2024
Obligated$269K
Current value$269K
Potential value$269K

FLUZONE TRIVALENT PF HD SYRINGE is a federal award for 261-Network Contract Office 21 (36C261) held by Sanofi Pasteur Inc. Estimated value $269K ($269K obligated). Current period of performance ends Oct 31, 2024. Place of performance: SWIFTWATER PA.

Recompete timing

Public
● Past PoP end (700 days ago)

Current PoP ended Oct 31, 2024 (700 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Bonuses end Sept 30

Want the durability read on 36C26124N0566? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Sanofi Pasteur Inc — $3.7B obligated across 396 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($3.7B) · all agencies · Top 4 shown (98%); remaining ~2% is other agencies.
Department of Health and Human Services (HHS)$3.6B · 97%Department of Defense (DOD)$29.1M · 1%Department of Veterans Affairs (VA)$6.9M · 0%Department of State (DOS)$2.4M · 0%
Open full company profile →

Related awards

Same parent · incumbent
15F06724F0000477
TRAVEL VACCINES.
$504K
Dec 31, 2026
15F06726F0000243
SANOFI TRAVEL VACCINES
$200K
Dec 31, 2026
75H71126F80051
THE NATIONAL SUPPLY SERVICE CENTER (NSSC), INDIAN HEALTH SERVICES (IHS), HAS A NEED FOR A …
$2.0M
Mar 14, 2027
75D30122F00001
VACCINE STORAGE AND ROTATION, 2021-2026
$163.3M
Sep 27, 2027
SPE2DP26F2910
8511928943!INFLUENZA VIRUS VAC
$3.0M
Sep 25, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C26124N0566?

36C26124N0566 (Fluzone trivalent PF HD syringe) is a 261-Network Contract Office 21 (36C261) award with a potential value of $269K, currently held by Sanofi Pasteur Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C261-24-N-0566?

36C261-24-N-0566 is the dashed form of PIID 36C26124N0566 (Fluzone trivalent PF HD syringe), held by Sanofi Pasteur Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26124N0566?

261-Network Contract Office 21 (36C261) awarded 36C26124N0566 to Sanofi Pasteur Inc (potential $269K).

Who is the incumbent on 36C26124N0566?

Sanofi Pasteur Inc is the incumbent with $3.7B across 396 related awards in SCOUT’s public footprint. The current period of performance ends Oct 31, 2024.

When does Sanofi Pasteur Inc’s 36C26124N0566 come up for recompete?

SCOUT tracks a period-of-performance end of Oct 31, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C26124N0566? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C26124N0566